期刊文献+

重组水疱性口炎病毒载体病毒包装体系的建立及优化 被引量:3

Establishment and Optimization of Recombinant VSV Packaging System
下载PDF
导出
摘要 目的:建立并优化重组水疱性口炎病毒(VSV)载体病毒包装体系,以获得稳定高效的重组VSV载体疫苗包装系统。方法:以prVSVΔG-GFP为骨架载体,pBS-N、pBS-P、pBS-G、pBS-L为辅助载体,探索不同的骨架质粒及辅助质粒用量、包装细胞系、重组痘病毒vTF7-3作用时间、转染试剂作用时间等因素对重组VSV载体病毒包装的影响,用光学显微镜及荧光显微镜观测重组VSV载体病毒的包装效果,应用TCID50法测定重组VSV的滴度。结果:重组VSV的包装效率随着辅助质粒或包装质粒总量的减少而降低,293T细胞较BHK21-WI2细胞包装效率更高,适当延长重组痘病毒vTF7-3作用时间或转染试剂作用时间能提高VSV包装效率。优化的病毒包装条件为:选用293T细胞,v TF7-3以5~15 MOI感染细胞1 h或以5 MOI感染细胞1~4 h,总质粒用量为3.67~22μg,转染细胞6~14 h可获得高效包装的rVSVΔG-GFP。采用优化包装条件高效包装了rVSVΔG-ZE病毒。结论:获得了稳定高效的重组VSV包装体系,为重组VSV载体的疫苗研究奠定了基础。 Objective:To establish a stable and efficient recombinant vesicular stomatitis virus(VSV)packaging system for vaccine preparation,the recombinant VSV packaging system was investigated and optimized.Methods:Using prVSVΔG-GFP as a scaffold vector,we explored the effects of different amount of scaffold and helper plasmids,different packaging cell lines,reaction time of recombinant poxvirus vTF7-3 and time of transfection on recombinant VSV packaging.Light microscope and fluorescence microscopy were used to determine the packaging effect of the recombinant VSV.The titer of the recombinant VSV was determined by TCID50 method.Results:The packaging efficiency of VSV decreased along with the decrease of the total amount of helper plasmids and packaging plasmids.When the amount of helper plasmids was constant,the packaging efficiency decreased along with the reduction of the scaffold plasmid.The packaging efficiency in 293T cells was more efficient than that of BHK21-WI2 cells.Proper reaction time and transfection time of the recombinant poxvirus vTF7-3 were necessary to increase the packaging efficiency of the VSV.The optimized rVSVΔG-GFP packaging conditions were as follows:293T cells were infected by vTF7-3 at a multiplicity of infection(MOI)of 5~15 for 1 h or 5 MOI for 1~4 h,3.67~22μg of total plasmids were used to transfect cells for 6~14 h.Finally,the packaged rVSVΔG-ZE virus was successfully and efficiently established.Conclusion:A stable and efficient VSV packaging system was established,which lay the foundation for preparation of recombinant VSV vector vaccine.
作者 卢建博 郑文铝 余云舟 叶建强 戴秋云 刘珠果 LU Jian-Bo;ZHENG Wen-Lyu;YU Yun-Zhou;YE Jian-Qiang;DAI Qiu-Yun;LIU Zhu-Guo(Beijing Institute of Biotechnology,Beijing 100071;Veterinary College,Yangzhou University,Yangzhou 225100,China)
出处 《生物技术通讯》 CAS 2018年第2期183-188,共6页 Letters in Biotechnology
基金 国家传染病防治科技重大专项(2016ZX10004001)
关键词 重组水疱性口炎病毒载体 包装体系 寨卡病毒 优化 recombinant vesicular stomatitis virus(VSV) packaging system Zika virus optimization
  • 相关文献

参考文献3

二级参考文献15

  • 1温志远,葛金英,王永,胡森,郝永清,步志高.水泡性口炎病毒印第安纳株反基因操作系统的建立[J].中国预防兽医学报,2006,28(5):489-494. 被引量:10
  • 2侯粉霞,杨慧芳,鱼涛.脂多糖及伴刀豆球蛋白A诱导脾淋巴细胞增殖试验方法用于免疫毒性评价的可行性研究[J].工业卫生与职业病,2007,33(6):336-339. 被引量:13
  • 3Rougeron V, Feldmann H, Grard G, et al. Ebola and Marburg haemorrhagic fever [J]. J Clin Virol, 2015, 64:111-119.
  • 4Feldmann H, Slenczka W, Klenk H D. Emerging and reemerg- ing of filoviruses [J]. Arch Virol Suppl, 1996, 11: 77-100.
  • 5Geisbert T W, Feldmann H. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections [J]. J Infect Dis, 2011, 204(3): 1075-1081.
  • 6Geisbert T W, Daddario-Dicaprio K M, Geisbert J B, et al. Vesicular stomatitis virus-based vaccines protect nonhuman pri- mates against aerosol challenge with Ebola and Marburg viruses [J]. Vaccine, 2008, 26(52): 6894-6900.
  • 7Manicassamy B, Wang Ji-zhen, Jiang Hai-qing, et al. Compre- hensive analysis of ebola virus GP1 in viral entry [J]. J Virol, 2005, 79: 4793-4805.
  • 8Hevey M, Negley D, Geisbert J, et al. Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants [J]. Virology, 1997, 239(1): 206-216.
  • 9Garbutt M, Liebscher R, Wahl-Jensen V, et al. Properties of replication-competent vesicular stomatitis virus vectors express- ing glycoproteins of filoviruses and arenaviruses [J]. J Virol, 2004, 78(10): 5458-5465.
  • 10Geisbert T W, Geisbert J B, Leung A, et al. Single-injection vaccine protects nonhuman primates against infection with mar- burg virus and three species of ebola virus [J]. J Virol, 2009, 83 (14): 7296-7304.

共引文献7

同被引文献10

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部